Novo Nordisk’s shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe’s ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market. Read why I ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

Novo Nordisk (NYSE:NVO) rose to its highest level in over two months Monday after a media report said hedge fund Parvus Asset ...

Hedge fund aims to influence CEO appointment as drugmaker battles share price slump and competition from Eli Lilly.

I wish Larry the best as he takes over as the next CEO of Hightower." Oros will remain a member of the Board, ensuring strategic continuity and a seamless transition for the firm's growing client base ...

He succeeds Founder and CEO Vish Sastry Rachakonda, who will transition to the role of Executive Chairman. To support iQuanti's transformation into an AI-first company, Sen brings over two decades ...

The CEO of a 50-year-old packaging company reveals the twists and turns on the path to employee ownership, including a pandemic-induced pause. The Arch City Report Live! Meet the SLBJ editorial ...

CEO and Co-Founder of Kouper Health. He shares how Kouper is using generative AI to streamline care transitions, reduce readmissions, and improve follow-up rates—offering actionable insights on ...